SCHEMBL13657384

SCHEMBL13657384

C=C1NC(=O)N(Cc2ccc3c(c2)OCO3)C1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 1/20 0.64
TSHR P16473 3/20 0.60
KMT2A Q03164 3/20 0.60
PKM P14618 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
LMNA P02545 1/20 0.52
GAA P10253 1/20 0.52
RAB9A P51151 1/20 0.52
HPGD P15428 3/20 0.51
SCN9A Q15858 1/20 0.51
PRKCE Q02156 1/20 0.50
ALDH1A1 P00352 6/20 0.48
MAPT P10636 3/20 0.47
USP2 O75604 2/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CHRM5 P08912 1/20 0.46
ALDH3A1 P30838 1/20 0.46
MEN1 O00255 2/20 0.45
HSP90AA1 P07900 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13657468 0.78 CMA1 (0.64) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL13657343 0.77 CMA1 (0.62) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL5768481 0.76 CMA1 (0.76) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL1080694 0.76 CMA1 (0.76) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL19500873 0.75 KMT2A (1.00) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL13657336 0.75 CMA1 (0.59) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL14681264 0.72 TSHR (0.64) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL4597260 0.71 ALDH1A1 (0.76) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL4013109 0.71 CMA1 (0.62) CMA1TSHRKMT2APKMSMN1; SMN2
SCHEMBL29721572 0.71 KMT2A (0.68) CMA1KMT2APKMSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 CMA1 3946/4885TSHR 279/4885KMT2A 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.